The Danforth Technology Company (DTC) today announced the launch of Spearhead Bio, a startup pioneering a breakthrough ...

Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year moratorium on ...

Nonhuman primate (NHP) study in hemophilia A demonstrated therapeutically relevant factor VIII (FVIII) activity with durable response through approximately 19 months with an encouraging safety profile ...

CellFE, a leader in microfluidics-based cell engineering, and Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO), today announced a strategic ...

Good morning, tech fam; here are some quick tech updates for you to catch up on! What’s New Today: TSMC introduces “System on ...

The PIC in Genus PIC stands for Pig Improvement Company. In a statement, Genus explained that gene-edited pigs won’t be ...

Company to share in vivo preclinical data demonstrating the successful use of targeted lipid nanoparticles to deliver HBG1/2 promoter editing cargo to hematopoietic stem and progenitor cells (HSPCs) ...

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

In this op-ed, Charles Gersbach explores how genetic tuning is emerging as a next-generation approach to modulating gene ...

A new agtech company focused on enhancing gene editing for plants has launched in St. Louis, the Danforth Technology Company ...

Poster presentation to demonstrate EBT-107’s potential to reduce clinically-relevant biomarkers and HBV DNA integration toward functional remission of chronic hepatitis B ; Oral ...

The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 vector technology.